Similar articles for PMID: 15528942

Year	Number of Results
1949	1
1953	3
1981	1
1996	2
1997	2
1999	1
2000	4
2001	1
2002	3
2003	3
2004	8
2005	8
2006	3
2007	4
2008	1
2009	2
2010	4
2011	5
2012	6
2014	1
2017	1
2018	1
2019	8
2020	2
2022	1
2023	2
2024	0

1

Effects of intravenously administered iron on systemic blood pressure in hemodialysis patients.

Ullian ME, Gadegbeku CA. Ullian ME, et al. Nephron Clin Pract. 2004;98(3):c83-6. doi: 10.1159/000080678. Nephron Clin Pract. 2004. PMID: 15528942

2

The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.

Cavdar C, Temiz A, Yeniçerioğlu Y, Calişkan S, Celik A, Sifil A, Onvural B, Camsari T. Cavdar C, et al. Scand J Urol Nephrol. 2003;37(1):77-82. doi: 10.1080/00365590310008758. Scand J Urol Nephrol. 2003. PMID: 12745750 Clinical Trial.

3

Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.

Li H, Wang SX. Li H, et al. Blood Purif. 2008;26(2):151-6. doi: 10.1159/000113529. Epub 2008 Jan 22. Blood Purif. 2008. PMID: 18212498 Clinical Trial.

4

Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.

Aronoff GR, Bennett WM, Blumenthal S, Charytan C, Pennell JP, Reed J, Rothstein M, Strom J, Wolfe A, Van Wyck D, Yee J; United States Iron Sucrose (Venofer) Clinical Trials Group. Aronoff GR, et al. Kidney Int. 2004 Sep;66(3):1193-8. doi: 10.1111/j.1523-1755.2004.00872.x. Kidney Int. 2004. PMID: 15327417 Free article. Clinical Trial.

5

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.

Coyne DW, Kapoian T, Suki W, Singh AK, Moran JE, Dahl NV, Rizkala AR; DRIVE Study Group. Coyne DW, et al. J Am Soc Nephrol. 2007 Mar;18(3):975-84. doi: 10.1681/ASN.2006091034. Epub 2007 Jan 31. J Am Soc Nephrol. 2007. PMID: 17267740 Clinical Trial.

6

Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.

Malindretos P, Sarafidis PA, Rudenco I, Raptis V, Makedou K, Makedou A, Grekas DM. Malindretos P, et al. Am J Nephrol. 2007;27(6):572-9. doi: 10.1159/000107928. Epub 2007 Sep 5. Am J Nephrol. 2007. PMID: 17804904 Clinical Trial.

7

Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.

Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warnock DG; Ferrlecit Publication Committee. Michael B, et al. Kidney Int. 2002 May;61(5):1830-9. doi: 10.1046/j.1523-1755.2002.00314.x. Kidney Int. 2002. PMID: 11967034 Free article. Clinical Trial.

8

Trends in intravenous iron use among dialysis patients in the United States (1994-2002).

St Peter WL, Obrador GT, Roberts TL, Collins AJ. St Peter WL, et al. Am J Kidney Dis. 2005 Oct;46(4):650-60. doi: 10.1053/j.ajkd.2005.06.018. Am J Kidney Dis. 2005. PMID: 16183420

9

[Iron replacement in hemodialysis patients with a normal serum ferritin level].

Riedel MK, Morgenstern T. Riedel MK, et al. Dtsch Med Wochenschr. 2004 Sep 3;129(36):1849-53. doi: 10.1055/s-2004-831347. Dtsch Med Wochenschr. 2004. PMID: 15368155 German.

10

Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis.

Rangel EB, Espósito BP, Carneiro FD, Mallet AC, Matos AC, Andreoli MC, Guimarães-Souza NK, Santos BF. Rangel EB, et al. Ther Apher Dial. 2010 Apr;14(2):186-92. doi: 10.1111/j.1744-9987.2009.00786.x. Ther Apher Dial. 2010. PMID: 20438541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year